• 2-Deoxy-D-glucose: Metabolic Checkpoint Targeting in Tumo...

  2025-10-22

  Unlock the advanced potential of 2-Deoxy-D-glucose as a glycolysis inhibitor and metabolic oxidative stress inducer. Explore how 2-DG uniquely intersects with tumor immunometabolism, ATP synthesis disruption, and emerging immunotherapeutic strategies.

• LY2603618: Unveiling New Frontiers in Chk1 Inhibition and...

  2025-10-21

  Explore how LY2603618, a selective Chk1 inhibitor, is revolutionizing research into DNA damage response and genome stability. This article uniquely integrates emerging insights on nuclear cGAS, L1 retrotransposition, and cancer therapy sensitization.

242 records 17/17 page Previous First page 上5页 1617